Multiple serum antibody levels to citrullinated and non-citrullinated antigens are elevated in Early RA compared to At-Risk, with limited but informative differences between At-Risk and anti-CCP3(−) Controls. This evidence concerns the gene AGBL3 and rheumatoid arthritis.